Market
Dialybrid raises $17m to advance Silkothane device
Dialybrid closed a €15 million Series A funding round to advance development of its Silkothane arteriovenous graft for hemodialysis vascular access. The capital will support the progression of the device intended to improve outcomes in dialysis patients requiring long-term access.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network